Abstract: A cartridge which is to receive a pasty material and has a cylindrical hollow cartridge body and a de-aeratable piston comprises a two-part piston consisting of a piston part and cover part in which the cover part seals the de-aeration path after the de-aeration.

Abstract: Dental materials with high abrasion resistance and their use for producing artificial teeth and/or their enamel or cutting areas are described. The materials primarily contain: (a) Monofunctional meth-/acrylates ?20-50% (b) Crosslinking meth-/acrylate ??1-20% (c) Splitter polymer from components (2) and (5) ??2-30% (d) PMMA-pearl polymers, partly crosslinked ??2-50% (e) Pyrogenic silicic acid, silanated ??0-20% (f) Inorganically fortified pearl polymer ??5-50% (g) Initiator components 0.1-1% (h) Coloring pigments 0.1-3%.

Abstract: Stable packaging for a dental implant, having a rigid enclosure and an implant holder situated therein, which enclosure is able to stand on two different planes, has a receptacle for the implant holder, an opening for access to the implant holder, and/or an implant held in the implant holder, and which implant holder has a recess for accommodating the implant.

Abstract: The production and use of a porous body with an antibiotic coating is described. A coating composed of at least one antibiotic salt, sparingly soluble in water or in an aqueous environment, from the group comprising fusidic acid-antibiotics, for example, fusidic acid-gentamicin, fusidic acid-sisomicin, fusidic acid-netilmicin, fusidic acid-streptomycin, fusidic acid-tobramycin, fusidic acid-spectinomycin, fusidic acid-vancomycin, fusidic acid-ciprofloxacin, fusidic acid-moxifloxacin, fusidic acid-clindamycin, fusidic acid-lincomycin, fusidic acid-tetracycline, fusidic acid-chlorotetracycline, fusidic acid-oxytetracycline, and fusidic acid-rolitetracycline is introduced into the pore system of nonmetallic porous bodies and metallic porous bodies. The antibiotically coated porous bodies are used as implants.

Abstract: The invention relates to a syringe for delivering flowable and/or highly viscous materials with a syringe tube, which has an outlet nozzle, a material container, which is disposed therein, a handle, which is disposed at the end of the syringe tube opposite to the outlet nozzle, and a syringe piston, which can be moved through the handle into the syringe tube. A safe operation is assured, even when larger pressures are exerted, owing to the fact that the handle is connected by means of a thread to the syringe tube and the material container has a closed lateral surface around the axis.

Abstract: Implant (1) for receiving the connecting bridge (17, 17?, 17?) of a medical device, comprising a longitudinal axis (9), a distal end (3) and a proximal end (4), whereby a receiving recess (10) for the connecting bridge (17, 17?, 17?) extends therefrom inside the implant (1), wherein the implant (1) can be connected on its outer surface area to the inner surface area of a receiving bore hole in a bone by force or adaptation, and whereby the connecting bridge (17, 17?, 17?), which is adapted to the receiving recess (10), can be anchored through clamping, shrinkage, adhesion or cementing. The anchored medical device rests on a contact surface (18) of the top (16) protruding radially outward in its cross-section beyond the cross-section of the receiving recess (10) on the proximal end (4) of the implant (1) across the entire surface against an allocated contact surface (5) of the implant (1) on its proximal end (4).

Abstract: A dental impression or doubling composition comprising alkoxysilyl-functional polyethers, having 20-95% polyether groups, 0.2 to 25% SiR1R2R3 groups and 0-10% urethane or urea groups, and a mixture comprising water and organic or inorganic acids, or both.

Abstract: The invention relates to a device and a method for manufacturing a dental prosthesis with which and in which the data records for fabricated teeth are fitted into a virtual model of the oral situation. It is possible to subsequently directly manufacture the denture base or to insert the fabricated teeth in the model.

Abstract: Curable dental compositions containing fine-particle anion exchangers exhibit excellent curing, even on dental surfaces that have been pretreated with acidic components.

Abstract: Two-component preparation on the basis of silane functionalized polyether derivatives, which cures into an elastomer product after the mixing of a base component containing silane functionalized polyether derivate with a catalyst component containing organic or inorganic acid, wherein the base component comprises an antiacid.

Abstract: An antibiotic polymer combination/antibiotics polymer combination that ensures the continuous release of antibiotics over a period of several days under physiological conditions, and that can be used in human and veterinary medicine.

Abstract: A photocurable dental coating material comprises

Abstract: A dental molding, in particular an artificial tooth, having an outer incisal layer and a dentin layer beneath that, characterized in that a layer of fluorescent material is provided between the dentin layer and the incisal layer. A method of producing the dental molding, and a method of using the dental molding to provide a patient with a more aesthetic appearance are also disclosed.

Abstract: The invention pertains to a device for electrodepositing metallic, prosthetic, molded, dental components, whereby the device has a glass beaker for accommodating an electrolyte bath, a stirring system for moving the electrolyte bath, a heating system for heating the electrolyte bath, at least one anode and at least one cathode, as well as a unit for supplying electricity that is connected to at least one of the anodes and to at least one of the cathodes. Use is hereby made of a heating system that is formed from at least one infrared emitter whose main emission is in the 0.5 &mgr;m to 1000 &mgr;m range of wavelengths.

Abstract: The present invention relates to a process for the sterilization and/or germ reduction of impression material by means of radiation.

Abstract: The invention relates to hardly soluble antiphlogistic salts and antiphlogistic-antibiotic pharmaceutical preparations and their use. The hardly water soluble antiphlogistic antibiotics salts have as their cationic component one of the antibiotics gentamicin, clindamycin, neomycin, streptomycin, tetracycline, doxicyline, oxytetracycline and rolitetracycline and as their anionic component one of the antiphlogistics ibuprofen, naproxen, indomethacin, dexamethasone-21-phosphate, dexamethasone-21-sulfate, triamcinolone-21-phosphate and triamcinolone-21-sulfate. The antiphlogistic antibiotics salts are used in pharmaceutical preparations as controlled-release antibiotic/antibiotics drugs.

Abstract: The invention describes pharmaceutical preparations with retarding active ingredient release, which consist of mixtures of powdery teicoplanin and at least one powdery, water soluble salt form of gentamicin, clindamycin, kanamycin, amikacin, tobramycin, vancomycin, moxifloxacin and ciprofloxacin and an inorganic and/or organic adjuvant. The pharmaceutical preparations are used as permanent or as temporary implants in the form of tablets, molded bodies, fibers and granules.

Abstract: The invention describes an antibiotic coating for porous bodies and its use. Into the porous system of non-metallic porous bodies and of metallic porous bodies, a coating made of at least one antibiotic salt that is hardly soluble in water or in an aqueous environment from the group of the netilmicin laurate, the netilmicin myristate, the netilmicin dodecyl sulfate, the sisomicin laurate, the sisomicin myristate, the sisomicin dodecyl sulfate, the gentamicin laurate, the gentamicin myristate, the clindamycin laurate, the amikacin laurate, the amikacin myristate, the amikacin dodecyl sulfate, the kanamycin laurate, the kanamycin myristate, the kanamycin dodecyl sulfate, the tobramycin laurate, the tobramycin myristate, the tobramycin dodecyl sulfate, the ciprofloxacin myristate, the vancomycin dodecyl sulfate, the vancomycin laurate, the vancomycin myristate, the vancomycin teicoplanin and the clindamycin teicoplanin is introduced. The antibiotically coated, porous bodies are used as implants.

Abstract: A bone cement mixture comprised of a polymer component containing an x-ray contrast medium and a monomer component, wherein the x-ray contrast medium is a polymer or copolymer having compounds of radio-opaque elements bonded thereto, or is in the form of substantially spherical polymer or copolymer particles with radio-opaque inorganic nano-particles dispersed therein.

Abstract: The present invention provides a method of microbial reduction and/or sterilization of impression materials, specifically elastomeric impression materials, by means of steam sterilization.